Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma

Journal of Neuro-Oncology

Volumn 71, Issue 2, 2005, Pages 173-180

  Raizer, Jeffrey J ^a   Koutcher, J A ^b   Abrey, L E ^b   Panageas, K S ^b   DeAngelis, L M ^b   Lis, E ^b   Xu, S ^c   Zakian, K L ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Magnetic resonance spectroscopy; Primary central nervous system lymphoma

Indexed keywords

CHOLINE; CREATININE; LACTIC ACID; LIPID; METHOTREXATE; N ACETYLASPARTIC ACID; ANTINEOPLASTIC ANTIMETABOLITE; ASPARTIC ACID; CREATINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; N-ACETYLASPARTATE; PROTON;

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; DRUG MEGADOSE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; KAPLAN MEIER METHOD; MALE; NON INVASIVE MEASUREMENT; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RISK ASSESSMENT; SURVIVAL TIME; TUMOR GROWTH; CENTRAL NERVOUS SYSTEM TUMOR; DOSE RESPONSE; EVALUATION; IMMUNOCOMPETENCE; IMMUNOLOGY; LIPID METABOLISM; LYMPHOMA; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STANDARD; SURVIVAL; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ASPARTIC ACID; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHOLINE; CREATINE; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOCOMPETENCE; LACTIC ACID; LIPID METABOLISM; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROTONS; SURVIVAL ANALYSIS;

EID: 20144382622     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-1360-8     Document Type: Article

References (43)

1. MJ Fulham A Bizzi MJ Dietz HH Shih R Raman GS Sobering JA Frank AJ Dwyer JR Alger G Chiro Di 1992 Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance Radiology 185 675-686 1:CAS:528:DyaK3sXhsVClt7o%3D 1438744
2. D Ott J Hennig T Ernst 1993 Human brain tumors: Assessment with in vivo proton MR spectroscopy Radiology 186 745-752 1:STN:280:ByyC2MjlvVI%3D 8430183
3. WG Negendank R Sauter TR Brown JL Evelhoch A Falini ED Gotsis A Heerschap K Kamada BC Lee MM Mengeot E Moser KA Padavic-Shaller JA Sanders TA Spraggins AE Stillman B Terwey TJ Vogl K Wicklow RA Zimmerman 1996 Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study J Neurosurg 84 449-458
4. M.E. Meyerand J.M. Pipas A. Mamourian T.D. Tosteson J.F. Dunn 1999 Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy AJNR Am J Neuroradiol 20 117-123
5. C Dowling AW Bollen SM Noworolski MW McDermott NM Barbaro MR Day RG Henry SM Chang WP Dillon SJ Nelson DB Vigneron 2001 Preoperative proton MR spectroscopic imaging of brain tumors: Correlation with histopathologic analysis of resection specimens AJNR Am J Neuroradiol 22 604-612
6. IM Burtscher G Skagerberg B Geijer E Englund F Stahlberg S Holtas 2000 Proton MR spectroscopy and preoperative diagnostic accuracy: An evaluation of intracranial mass lesions characterized by stereotactic biopsy findings AJNR Am J Neuroradiol 21 84-93
7. MA Heesters RL Kamman EL Mooyaart KG Go 1993 Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy J Neurooncol 17 27-35
8. MC Preul Z Caramanos JG Villemure G Shenouda R LeBlanc A Langleben DL Arnold 2000 Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy Neurosurgery 46 306-318
9. R Tarnawski M Sokol P Pieniazek B Maciejewski J Walecki L Miszczyk T Krupska 2002 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas Int J Radiat Oncol Biol Phys 52 1271-1276
10. X Leclerc TA Huisman AG Sorensen 2002 The potential of proton magnetic resonance spectroscopy ((1)H-MRS) in the diagnosis and management of patients with brain tumors Curr Opin Oncol 14 292-298 10.1097/ 00001622-200205000-00007
11. MC Preul R LeBlanc Z Caramanos R Kasrai S Narayanan DL Arnold 1998 Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases Can J Neurol Sci 25 13-22
12. A Pirzkall T.R. McKnight E.E. Graves M.P. Carol P.K. Sneed WW Wara SJ Nelson LJ Verhey DA Larson 2001 MR-spectroscopy guided target delineation for high-grade gliomas Int J Radiat Oncol Biol Phys 50 915-928
13. EE Graves SJ Nelson DB Vigneron C Chin L Verhey M McDermott D Larson PK Sneed S Chang MD Prados K Lamborn WP Dillon 2000 A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas Neurosurgery 46 319-326
14. JP Rock D Hearshen L Scarpace D Croteau J Gutierrez JL Fisher ML Rosenblum T Mikkelsen 2002 Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis Neurosurgery 51 912-920
15. LL Wald SJ Nelson MR Day SE Noworolski RG Henry SL Huhn S Chang MD Prados PK Sneed DA Larson WM Wara M McDermott WP Dillon PH Gutin DB Vigneron 1997 Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy J Neurosurg 87 525-534 1:STN:280:ByiH283mtFI%3D 9322843
16. LE Abrey J Yahalom LM DeAngelis 2000 Treatment for primary CNS lymphoma: the next step J Clin Oncol 18 3144-3150
17. L.M. DeAngelis 1990 Primary central nervous system lymphoma imitates multiple sclerosis J Neurooncol 9 177-181
18. T Batchelor K Carson A O'Neill SA Grossman J Alavi P New F Hochberg R Priet 2003 Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: A report of NABTT 96-07 J Clin Oncol 21 1044-1049
19. Bottomley P: Selective volume method for performing localized NMR spectroscopy. Patent 4,480,228. 1984.
20. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457-481
21. PL Lee RG Gonzalez 2000 Magnetic resonance spectroscopy of brain tumors Curr Opin Oncol 12 199-204
22. IL Simone F Federico C Tortorella CF Andreula GB Zimatore P Giannini G Angarano V Lucivero P Picciola D Carrara A Bellacosa P Livrea 1998 Localised 1H-MR spectroscopy for metabolic characterization of diffuse and focal brain lesions in patients infected with HIV J Neurol Neurosurg Psychiatry 64 516-523
23. RJ Chinn ID Wilkinson MA Hall-Craggs MN Paley RF Miller BE Kendall SP Newman MJ Harrison 1995 Toxoplasmosis and primary central nervous system lymphoma in HIV infection: Diagnosis with MR spectroscopy Radiology 197 649-654
24. L Chang BL Miller D McBride M Cornford G Oropilla S Buchthal F Chiang H Aronow CK Beck T Ernst 1995 Brain lesions in patients with AIDS: H-1 MR spectroscopy Radiology 197 525-531
25. I Harting M Hartmann G Jost C Sommer R Ahmadi S Heiland K Sartor 2003 Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy Neurosci Lett 342 163-166 10.1016/S0304-3940(03)00272-6 1:CAS:528:DC%2BD3sXjvFahtbc%3D 12757890
26. MC Preul Z Caramanos DL Collins JG Villemure R LeBlanc A Olivier R Pokrupa DL Arnold 1996 Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy Nat Med 2 323-325 1:CAS:528:DyaK28XhsVGkt7s%3D 8612232
27. S Herminghaus U Pilatus W Moller-Hartmann P Raab H Lanfermann W Schlote FE Zanella 2002 Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors NMR in Biomedicine 15 385-392
28. F Podo 1999 Tumour phospholipid metabolism NMR in Biomedicine 12 413-439
29. RK Gupta TF Cloughesy U Sinha J Garakian J Lazareff G Rubino L Rubino DP Becker HV Vinters JR Alger 2000 Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma J Neurooncol 50 215-226
30. H Shimizu T Kumabe R Shirane T Yoshimoto 2000 Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas AJNR Am J Neuroradiol 21 659-665
31. ED Gotsis K Fountas E Kapsalaki P Toulas G Peristeris N Papadakis 1996 In vivo proton MR spectroscopy: The diagnostic possibilities of lipid resonances in brain tumors Anticancer Res 16 1565-1567
32. W Negendank R Sauter 1996 Intratumoral lipids in 1H MRS in vivo in brain tumors: Experience of the Siemens cooperative clinical trial Anticancer Res 16 1533-1538
33. M Rijpkema J Schuuring MY Van Der GM Van Der H Bernsen R Boerman A van der Kogel A Heerschap 2003 Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging NMR Biomed 16 12-18
34. M Tomoi H Kimura M Yoshida S Itoh Y Kawamura N Hayashi K Yamamoto T Kubota Y Ishii 1997 Alterations of lactate (+lipid) concentration in brain tumors with in vivo hydrogen magnetic resonance spectroscopy during radiotherapy Invest Radiol 32 288-296
35. A Bizzi B Movsas G Tedeschi CL Phillips P Okunieff JR Alger G Chiro Di 1995 Response of non-Hodgkin lymphoma to radiation therapy: Early and long- term assessment with H-1 MR spectroscopic imaging Radiology 194 271-276
36. AC Kuesel KM Briere WC Halliday GR Sutherland SM Donnelly IC Smith 1996 Mobile lipid accumulation in necrotic tissue of high grade astrocytomas Anticancer Res 16 1485-1489
37. KT Holmes CL Lean NH Hunt NJ King 1990 Development of the "ctivated" high resolution 1H MR spectrum in murine T cells and B cells occurs in G1 phase of the cell cycle Magn Reson Med 16 1-8
38. PF Agris ID Campbell 1982 Proton nuclear magnetic resonance of intact Friend leukemia cells: Phosphorylcholine increase during differentiation Science 216 1325-1327
39. E Braks H Urbach H Pels F Traber W Block HH Schild 2000 Primary central nervous system immunocytoma: MRI and spectroscopy Neuroradiology 42 738-741
40. FA Howe SJ Barton SA Cudlip M Stubbs DE Saunders M Murphy P Wilkins KS Opstad VL Doyle MA McLean BA Bell JR Griffiths 2003 Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy Magn Reson Med 49 223-232
41. AA Tzika D Zurakowski TY Poussaint L Goumnerova LG Astrakas PD Barnes DC Anthony AL Billett NJ Tarbell RM Scott PM Black 2001 Proton magnetic spectroscopic imaging of the child's brain: The response of tumors to treatment Neuroradiology 43 169-177
42. CM Segebarth DF Baleriaux DL Arnold PR Luyten JA Hollander den 1987 MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment Radiology 165 215-219
43. R Lai MK Rosenblum LM DeAngelis 2002 Primary CNS lymphoma - A whole-brain disease? Neurology 59 1557-1562